Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.
Abhishek PratapDaniel GrantAshok VegesnaMeghasyam TummalacherlaStanley L CohanChinmay DeshpandeLara M MangraviteLarsson OmbergPublished in: JMIR mHealth and uHealth (2020)
The elevateMS study app captured the real-world experience of MS, characterized some MS symptoms, and assessed the impact of environmental factors on symptom severity. Our study provides further evidence that supports smartphone app use to monitor MS with both active assessments and patient-reported measures of disease burden. App-based tracking may provide unique and timely real-world data for clinicians and patients, resulting in improved disease insights and management.
Keyphrases
- multiple sclerosis
- patient reported
- mass spectrometry
- healthcare
- ms ms
- public health
- end stage renal disease
- ejection fraction
- randomized controlled trial
- palliative care
- clinical trial
- prognostic factors
- risk assessment
- cross sectional
- deep learning
- peritoneal dialysis
- health information
- climate change
- patient reported outcomes